Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SynAct strengthens IP portfolio – Grant of key European patent covering AP1189

SynAct Pharma AB ("SynAct") today announced that a European patent was granted covering the company’s leading drug candidate AP1189 in methods of treating kidney diseases.SynAct has received information that its European patent EP 3 743 064 B1 was granted on 11 August 2021. The European patent provides exclusivity on the medical use of AP1189 and similar compounds in treating kidney disease, specifically primary nephrotic syndrome, and including membranous nephropathy which is currently being tested in clinical trials. The European patent will now be validated in selected European

Invitation to SAS’ Q3 2021 teleconference

SAS will publish the interim report for the third quarter of the fiscal year 2021 on Wednesday, 1[st] of September 2021, at approximately 08.00 AM (CET). A teleconference and webcast for investors, analysts and media will be held at 10.00 AM (CET). Anko van der Werff, President & CEO and Magnus Örnberg, Executive Vice President & CFO will present and comment the report. The presentation will be held in English via telephone or https://www.sasgroup.net No advance notification is necessary. Dial-in details for the conference call: DK: +45 354 455 77FI: +358 981 710 310NO:

SSG – Disclosure of large shareholding

Reference is made to the stock exchange notification on 24 August 2021 from Self Storage Group ASA (the “Company”) regarding a private placement of NOK 10,350,000 new shares (the "New Shares") in the Company (the “Private Placement”) at a subscription price of NOK 29 per share. Centerbridge Partners L.P has been allocated 3,620,000 new shares in the Private Placement. After completion of the Private Placement, Centerbridge Partners L.P will hold 24,557,078 shares in the Company, which, after issue and registration of the New Shares, will represent approximately 25.94% of the total issued

TOMRA: Mandatory notification of trade

Harald Henriksen, Executive Vice President, Head of TOMRA Collection Solutions and primary insider of TOMRA Systems ASA, has today sold 14,000 shares in TOMRA Systems ASA at a price of NOK 510.00 per share. After the transaction Harald Henriksen holds 41,052 shares in TOMRA Systems ASA.   This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Financial report for the period January 1 2021 – June 30 2021

Company Announcement No. 9-2021 OrderYOYO A/SInside Information   Copenhagen, August 25, 2021Financial Highlights – strong net revenue growth of 82% H1 2021 vs H1 2020 · Strong net revenue growth H1 2021 vs H1 2020 of 82% - to DKK 53.6m in H1 2021 · Strong ARR growth based in June 2021 compared to June 2020 of 31% - to DKK 105.4m · Solid GMV growth H1 2021 vs H1 2020 of 37% - to DKK 606m · GMV June 2021 as expected – June 2021 was the first month where Covid restrictions were lifted in all our markets which as expected meant a minor slowdown in the growth in take-

Invitation to presentation of Sectra’s three-month interim report 2021/2022

Linköping – August 25, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites analysts, investors, and the media to a presentation of the company’s three-month report with President Torbjörn Kronander and CFO Mats Franzén.Publication of the interim report: 8:15 a.m. (CEST) on September 3, 2021Report presentation: 10:00 a.m. (CEST) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q12122 . The broadcast

Anifera receives further investment from Stonehaven Incubate to initiate additional studies of adjunct therapy in bovine mastitis

· Bovine mastitis is a major economic and welfare challenge for the global dairy industry, reducing both milk yield and quality · Anifera’s unique mode of action aims to improve antibiotic efficacy and ultimately reduce the overall use of antibiotics in multiple disease statesLondon, UK, 25 August 2021 – Anifera, a company focused on developing adjunct therapy to improve the efficacy of antibiotics used in animal health, today announced that it plans to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis, a significant economic and

Launch of Pay by 24SevenOffice

24SevenOffice is pleased to announce the re-launch of the digital payment technology (previously called OptinPay) acquired from Optin Bank ASA. The digital payment solution has been named Pay by 24SevenOffice and is now in production. Since the acquisition of the technology 24SevenOffice has successfully managed to transfer the comprehensive technology platform, including taking over the hosting, re-negotiated necessary agreements and adapting the platform to the new situation.The first version of the payment solution includes flexible payment options through SMS, with card payment, mobile

NENT Group orders ‘Ida Takes Charge’ as latest Viaplay Original

· Series based on Kjersti Halvorsen’s acclaimed debut novel · ‘Ida Takes Charge’ stars Elli Rhiannon Müller Osborne (‘Psychobitch’; ‘Utøya: July 22’) and is directed by Student Academy Award winner Rikke Gregersen · NENT Group to premiere at least 50 original productions in 2021 ‘Ida Takes Charge’, a darkly humorous Norwegian drama series based on the critically acclaimed debut by young novelist Kjersti Halvorsen and directed by rising star Rikke Gregersen, will be the next Viaplay Original from Nordic Entertainment Group (NENT Group). The eight-part series stars Elli Rhiannon

Holmström Fastigheter investigates the possibility to issue subsequent bonds

Holmström Fastigheter Holding AB (publ) (”Holmström Fastigheter”) has mandated Nordea and Pareto as ’joint bookrunners’ to investigate the possibility of issuing subsequent senior unsecured bonds (the “New Bonds”), under its existing bond framework of SEK 750,000,000 with ISIN: SE0015797667. Holmström Fastigheter has, as previously published, on 14 April 2021, issued SEK 300,000,000 under the bond framework. A market transaction may follow, subject to market conditions. The net proceeds from the New Bonds will be used for general corporate purposes including acquisition of properties.

"myFC is targeting a rapidly growing billion-dollar market" – Tim Hannig, senior Business Advisor at myFC

According to Tim Hannig, Senior Business Advisor to the board of management of myFC, with a background in Kion group, Jaguar Land Rover, and other OEM companies, myFC is taking important steps to future business agreements with a leading OEM that develops automatic warehouse robots.– Intralogistics is an exciting and commercially significant segment where myFC’s technology also provides crucial benefits. myFC is entering a rapidly growing market with a strong market drive, he says.Intralogistics appears to be an expansive business area; can you tell us more?– One reason for the rapid

Kristina Olsen to leave Bonava

Kristina Olsen has decided to leave Bonava and her role of BU President of Bonava Norway to work with an external assignment. Jonas Granström has been appointed Acting BU President and member of the Executive Management Group.Kristina Olsen has worked at NCC/Bonava since 2000 and held several senior positions at the company, including as BU President Bonava Denmark-Norway. She has been a member of Bonava’s Executive Management Group since 2018. – I would like to extend my sincere gratitude to Kristina for her highly appreciated work during her time at Bonava. I wish Kristina much success

Janes at the heart of the British Army’s first AI-driven battlefield operation

The trusted global agency for open-source defence intelligence is proud to have played a major role in the first use of Artificial Intelligence on deployed operations by the British Army during Exercise ‘Spring Storm’.LONDON (25 August 2021) – Interconnecting with third-party data and systems, Janes foundational intelligence was integral during the first use of Artificial Intelligence (AI) on deployed operations by the British Army. Soldiers from the 20[th] Armoured Infantry Brigade used an AI engine – incorporating Janes interconnected intelligence – to provide information on the

Safello to host a new AMA session in Discord

Stockholm, 25 August 2021 | Safello will follow up the recently published interim report for Q2 2021 with an AMA session targeting shareholders, users and other interested stakeholders in the Safello Community Discord channel. AMA (Ask Me Anything) offers a platform for Safello's broad community of users, shareholders and crypto enthusiasts to interact directly with Safello’s representatives, as well as ask any burning questions in a casual question-and-answer format. The second Community AMA session featuring CEO Frank Schuil will take place this Friday, August 27, 2021, at

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Eurocine Vaccines extends its product portfolio with a diagnostic test of chlamydia through a widened agreement with Spixia Biotechnology

Eurocine Vaccines AB has decided to evaluate a diagnostic test of chlamydia antibodies in blood as an extension of its portfolio and has widened the license agreement with Spixia Biotechnology AB to also include diagnostic tests of chlamydia.Chlamydia is a sexually transmitted bacterial disease that often leads to involuntary infertility in women (read more ). There is currently no prophylactic vaccine against chlamydia on the market and Eurocine Vaccines is developing a vaccine candidate based on a patented protein (read more 

STRAX: Interim Report No 2 for the financial year 2021

STRAX have again managed well through a period of continued market disruption related to the Covid-19 pandemic· The Group’s sales for the period January 1 – June 30, 2021, amounted to MEUR 54.8 (50.2), with a gross margin of 19.0 (23.7) percent.  · The Group’s result for the period January 1 – June 30, 2021, amounted to MEUR -2.0 (-2.8) corresponding to EUR -0.02 (-0.02) per share.  · EBITDA for the period January 1 – June 30, 2021, amounted to MEUR 1.6 (1.4). · Equity as of June 30 2021, amounted to MEUR 16.2 (17.3) corresponding to EUR 0.13 (0.15) per share. · STRAX

Altia and Arcus will complete the merger of Arcus into Altia; The Board of Directors of Altia has resolved on the payment of an extra dividend

ALTIA PLC      STOCK EXCHANGE RELEASE     25 August 2021 at 9:55 a.m. EEST THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. Altia and Arcus will

Arcus: Altia and Arcus will complete the merger of Arcus into Altia

THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. Arcus: Altia and Arcus will complete the merger of Arcus into Altia Altia Plc (“Altia”) and Arcus ASA (

Correction: Polymer Factory Sweden AB (publ) Interim Report Q2 2021

Correction of the previously disclosed press release; the MAR-label was added to the interim report in addition to being in the press release.The period in summary Second quarter, April-June 2021 · The company was listed on Spotlight Stock Market with first day of trading 7th April 2021. · A new CEO started 1st April 2021. · The loss for the period amounted to KSEK -922, of which KSEK 200 can be derived from IPO related activities. · Net sales for the period increased with 177% Q2. Year to date, January-June 2021 · The operating loss for the period amounted to KSEK -

The Global Change Award is Back, with New Scope

STOCKHOLM; August 25, 2021 – The world’s largest innovation challenge to transform the fashion industry is now open for applications. The Global Change Award 2022 is seeking early-stage innovations contributing to a planet positive fashion industry by addressing the earth’s global commons: land, water, oceans, climate and biodiversity. Winners get to share a grant of 1 million euro, provided by the H&M Foundation.The Global Change Award was initiated in 2015 by non-profit H&M Foundation, in collaboration with Accenture and the KTH Royal Institute of Technology. The award has attracted more

Extended Malaysian wound care tender

Bactiguard’s tender award for wound care products for the public sector in Malaysia has been extended by another year and the volume has increased. This enables healthcare providers in both primary and secondary care to purchase Bactiguard’s Wound Care system for infection prevention.“The public sector in Malaysia has consumed almost half a million bottles of our wound care products during the past five years with very positive outcome. Therefore, the Ministry of Health has extended the contract by another year with and increased the volume by 20 precent, which clearly shows that it adds

AcouSort: Interim Report 2021-04-01 – 2021-06-30

Second quarter (2021-04-01 – 2021-06-30) • Income amounted to TSEK 530 (1 448) • Result before tax amounted to TSEK -3 476 (-1 338) • Result per share was SEK -0,31 (-0,12) • Equity ratio amounted to 45 % (86 %) on 30 June 2021CEO Comments AcouSort has continued to develop well during the second quarter of the year. Our strategic collaborations continue to expand in the right direction. At the same time, interest in understanding and exploring our technology is growing and interest from the life science industry remains high strengthening our strategic investments in the OEM

Scandinavian ChemoTech AB (publ) Interim report Q2 January – June 2021 - Executive Summary of the second quarter

Second quarter · Net sales amounted to kSEK 5 (0) · Profit before tax amounted to kSEK - 3 796 (-2 557) · Earnings per share amounted to SEK -0,44 (-0,61) · Cash flow from operating activities totaled to kSEK -850 (-1 745) · The order book amounted to kSEK 1 122 (596) at the end of the quarter Period 1 January - 30 June · Net sales amounted to kSEK 30 (90) · Profit before tax amounted to kSEK -6 581 (-6 021) · Earnings per share amounted to SEK -0,81 (-1,59) · Cash flow from operating activities totaled to kSEK -6 414 (-5 865) · The order book amounted

There are no items matching the current filter
There are no more items matching the current filter
Back to top